New battle in CRISPR patent war adds to the uncertainty surrounding the technology

New battle in CRISPR patent war adds to the uncertainty surrounding the technology

New interference proceeding gives the University of California another shot at claiming exclusive rights to CRISPR-Cas9 gene-editing in human, animal and plant cells

Unlock unlimited access to all IAM content